https://musashigeneresearch.org/wp-content/uploads/2023/11/clear.png00Mathew Chvastahttps://musashigeneresearch.org/wp-content/uploads/2023/11/clear.pngMathew Chvasta2022-08-03 19:37:242023-08-03 19:38:13TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.